157 related articles for article (PubMed ID: 22961207)
1. Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer.
Kang WS; Cho SB; Park JS; Lee MY; Myung SC; Kim WY; Lee SH; Kim DH; Lee EJ
J Cancer Res Clin Oncol; 2013 Jan; 139(1):97-106. PubMed ID: 22961207
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of the VIM promoter in uterine cervical squamous cell carcinoma.
Lee MK; Jeong EM; Kim JH; Rho SB; Lee EJ
Oncology; 2014; 86(5-6):359-68. PubMed ID: 24942637
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of DKK3 is associated with adverse clinical outcomes of uterine cervical squamous cell carcinoma.
Ryu SW; Kim JH; Kim MK; Lee YJ; Park JS; Park HM; Kim DH; Lee SH; Lee EJ
Int J Gynecol Cancer; 2013 Jan; 23(1):134-40. PubMed ID: 23154266
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
[TBL] [Abstract][Full Text] [Related]
7. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
8. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients.
Hou T; Xiao J; Zhang H; Gu H; Feng Y; Li J
Int J Clin Exp Pathol; 2013; 6(6):1121-7. PubMed ID: 23696930
[TBL] [Abstract][Full Text] [Related]
10. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
Yuan CC; Wang PH; Ng HT; Tsai LC; Juang CM; Chiu LM
Eur J Gynaecol Oncol; 2002; 23(1):17-20. PubMed ID: 11876385
[TBL] [Abstract][Full Text] [Related]
11. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
[TBL] [Abstract][Full Text] [Related]
12. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
13. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
14. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
17. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
19. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
20. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.
Liu K; Zhang Y; Zhang C; Zhang Q; Li J; Xiao F; Li Y; Zhang R; Dou D; Liang J; Qin J; Lin Z; Zhao D; Jiang M; Liang Z; Su J; Gupta VP; He M; Yang X
Oncotarget; 2016 Aug; 7(35):56798-56810. PubMed ID: 27462864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
